In tandem, public perceptions of these medications are evolving significantly. With celebrities crediting the new treatments ...

Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

Lots of people want to lose weight but they don't necessarily want to take regular injections to do it. That's the finding of ...

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...